Patient Resources/Action Plans
This section contains the customizable action plans for patients with different tumor types that have been customized for the Australian audience. We wish to thank Tamara Dawson, of the Melanoma & Skin Cancer Advocacy Network, for her helpful review of these materials.
Talimogene laherparepvec; T-VEC
Pembrolizumab
- Bladder (Urothelial) Cancer
- Head and Neck Squamous Cell Carcinoma
- Hodgkin Lymphoma, Classical
- Lung Cancer, Non-Small Cell
- Melanoma
Nivolumab
- Bladder (Urothelial) Cancer
- Head and Neck Squamous Cell Carcinoma
- Hepatocellular Carcinoma
- Hodgkin Lymphoma, Classical
- Kidney Cancer (Renal Cell Carcinoma)
- Lung Cancer, Non-Small Cell
- Melanoma